D-0993-2019 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0993-2019 was initiated by Akorn, Inc. on Feb 22, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point. The recall status is terminated (terminated Aug 9, 2022). Affected quantity: 51,456 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Feb 22, 2019
Termination Date
Aug 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
51,456 bottles

Product description

Gentamicin Sulfate Ophthalmic Solution, USP, 0.3%, 5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-283-10.

Reason for recall

Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot 7B71A, Exp 01/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0993-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0993-2019. Report a data issue: hello@regdatalab.com.